Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-46373
J Dermatolog Treat 2019 Sep 01;306:617-626. doi: 10.1080/09546634.2018.1479726.
Show Gene links Show Anatomy links

Innovative nanocompounds for cutaneous administration of classical antifungal drugs: a systematic review.

Santos RS , Loureiro KC , Rezende PS , Andrade LN , de Melo Barbosa R , Santini A , Santos AC , Ferreira da Silva C , Souto EB , de Sousa DP , Amaral RG , Severino P .


???displayArticle.abstract???
Nanomedicine manipulates materials at atomic, molecular, and supramolecular scale, with at least one dimension within the nanometer range, for biomedical applications. The resulting nanoparticles have been consistently shown beneficial effects for antifungal drugs delivery, overcoming the problems of low bioavailability and high toxicity of these drugs. Due to their unique features, namely the small mean particle size, nanoparticles contribute to the enhanced drug absorption and uptake by the target cells, potentiating the therapeutic drug effect. The topical route is desirable due to the adverse effects arising from oral administration. This review provides a comprehensive analysis of the use of nano compounds for the current treatment of topical fungal infections. A special emphasis is given to the employment of lipid nanoparticles, due to their recognized efficacy, versatility, and biocompatibility, attracting the major attention as novel topical nanocompounds used for the administration of antifungal drugs.

???displayArticle.pubmedLink??? 29856232
???displayArticle.link??? J Dermatolog Treat